Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02246608 · ClinicalTrials.gov registry record · NA
Effect of Oasis® Wound Matrix on Stage III and IV Trunk Pressure Wounds Treated With Negative Pressure Wound Therapy
A NA study of Open Wound Abdominal Wall and Wound Non Healing, sponsored by Kettering Health Network.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT02246608: Completed NA study of Open Wound Abdominal Wall and Wound Non Healing, sponsored by Kettering Health Network.
NCT02246608 is a NA study of Open Wound Abdominal Wall and Wound Non Healing that has completed, run by Kettering Health Network. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02246608, a NA study of Open Wound Abdominal Wall and Wound Non Healing, has completed, sponsored by Kettering Health Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the therapeutic effect of Oasis® Matrix along with Negative Pressure Wound Therapy (NPWT) on pressure wounds. Either Oasis or standard foam will be applied to the wound prior to activating the NPWT.
Primary Outcome
Wound dimensions will be measured weekly and monitored for changes
Conditions Studied
Interventions
- DEVICE NPWT Standard of Care plus Oasis wound product
- DEVICE Routine NPWT Standard of Care
Study Locations (1)
Ohio
- Kettering Medical Center - Kettering
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2014-08 |
| Est. Completion | 2018-01 |
| Phase | NA |
What the finished NCT02246608 record still lists
NCT02246608 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Open Wound Abdominal Wall appearing as the primary indexed condition, and to 2 interventions - of which NPWT Standard of Care plus Oasis wound product is the first listed.
NCT02246608 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02246608 about?
NCT02246608 is a clinical study titled "Effect of Oasis® Wound Matrix on Stage III and IV Trunk Pressure Wounds Treated With Negative Pressure Wound Therapy". This study evaluates the therapeutic effect of Oasis® Matrix along with Negative Pressure Wound Therapy (NPWT) on pressure wounds. Either Oasis or standard foam will be applied to the wound prior to activating the NPWT.
What is the current status of trial NCT02246608?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2014-08. Estimated completion is 2018-01.
What conditions does trial NCT02246608 study?
This clinical trial studies the following conditions: Open Wound Abdominal Wall, Wound Non Healing.
What interventions are being tested in trial NCT02246608?
The interventions under investigation include: NPWT Standard of Care plus Oasis wound product (DEVICE), Routine NPWT Standard of Care (DEVICE).
Who is sponsoring clinical trial NCT02246608?
This trial is sponsored by Kettering Health Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02246608 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02246608's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia